SynCore Biotechnology Co Ltd (4192) — Cash Flow Quality Index
Latest as of December 2023:
-0.72x
SynCore Biotechnology Co Ltd (4192) has a Cash Flow Quality Index of -0.72x as of December 2023. Operating cash flow of NT$-30.14 Million is below net income of NT$41.62 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore SynCore Biotechnology Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-0.72x
Operating CF / Net Income
Operating Cash Flow
NT$-30.14 Million
TWD
Net Income
NT$41.62 Million
TWD
Data as of
Dec 2023
Most recent filing
Annual Cash Flow Quality Index for SynCore Biotechnology Co Ltd (None–None)
Year-by-year earnings quality comparison for SynCore Biotechnology Co Ltd. For live market cap and the full company financial profile, see SynCore Biotechnology Co Ltd (4192) total market value.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.